Thursday, November 19, 2026

Subscribe

NewsEdition DR CongoDR Congo

DR Congo: Bundibugyo Ebola tests response without a vaccine

The Democratic Republic of the Congo is facing its 17th Bundibugyo Ebola outbreak without an approved vaccine. More than 5,000 cases and 2,500 deaths have been reported in 100 days.

A small, formal group of health officials at a meeting on Ebola in Kinshasa.

An outbreak on a new scale

In the Democratic Republic of the Congo, the Ebola epidemic is no longer just a health alert. It is affecting travel, routine healthcare and the local economy, especially in the east, where the movement of workers, goods and patients remains intense. At this stage, the response no longer depends solely on hospitals: it is also playing out on roads, on the Congo River and in the trust of communities.

The country is no stranger to battling the virus. But the 17th outbreak, caused by the Bundibugyo strain, poses a different challenge: there is not yet an approved vaccine or treatment for this particular variant. The World Health Organization said at the end of May that the response should rely first on surveillance, rapid isolation, clinical care and community engagement.

Figures that signal urgency

As of 24 August 2026, data reported by the Associated Press on the basis of Congolese health authorities showed 5,375 confirmed cases and 2,557 deaths. The outbreak had then passed the 100-day mark since its official declaration on 15 May 2026, according to information corroborated by media and health institutions.

These figures illustrate particularly rapid transmission. The WHO said the outbreak began in May 2026 in the DRC and Uganda, before spreading in a difficult context: remote areas, high mobility, a humanitarian crisis and persistent insecurity. The UN agency also said the situation in the DRC remained deeply concerning and that the response depended on close monitoring of contacts and greater acceptance of health teams by residents.

For several weeks, the Congolese health ministry has been publishing daily situation reports, a sign that it now considers the epidemic a major operational front. The 20 August 2026 document is indeed listed among the official SitReps available on the ministry’s website.

Why the Bundibugyo strain complicates the response

The Bundibugyo strain belongs to the genus Orthoebolavirus. It is known, but there are fewer medical tools available against it than against the Zaire strain, for which a vaccine has already been used in past outbreaks. The WHO has confirmed that no vaccine or approved treatment for Bundibugyo is currently available. Candidates are nevertheless being studied, including an rVSV Bundibugyo vaccine and another based on ChAdOx1 Bundibugyo.

In short, the response must proceed without a full safety net. This means Congolese teams, the WHO and Africa CDC must rely on conventional public health measures: testing, contact tracing, protection for healthcare workers, controls on burials, community outreach and surveillance at crossing points. The WHO has also placed the response within the framework of the International Health Regulations, classifying the situation as a public health emergency of international concern.

Geography is another challenge. In eastern DRC, affected areas are often remote, crossed by trade routes and marked by population displacement. The WHO has highlighted a context combining a humanitarian crisis, insecurity and high mobility. In these circumstances, every delay in reporting increases the risk of silent transmission.

What the response means in practice

For medical teams, the urgency is twofold: to treat patients and to keep going. Healthcare workers are operating in an environment where capacity, logistics and security are fragile. The AP reported that efforts to combat the outbreak had been complicated by armed conflict, attacks on healthcare workers and facilities, a mobile workforce and a lack of critical infrastructure.

For residents, the effects are immediate. The disease is disrupting journeys between villages, markets, health centres and river ports. Stepped-up surveillance on the Congo River, mentioned in the source article, fits this approach: limiting uncontrolled crossings, especially between urban areas and more isolated zones. Even without a detailed statement to hand, this approach is consistent with the containment strategy described by the WHO.

For the Congolese state, the epidemic is also a test of governance. It is measuring Kinshasa’s ability to coordinate the provinces, supply treatment centres and speak with one voice alongside its partners. The announced arrival of 16,250 doses of Ervebo in Kinshasa on 22 August shows that international mobilisation is accelerating. But it is important to note that this vaccine, used against other forms of Ebola, is not officially approved for the Bundibugyo strain; according to the WHO, it could offer only partial protection.

A Congolese crisis with regional implications

The outbreak is crossing national borders. Uganda declared its local outbreak over on 28 July 2026, after 42 days without a new confirmed case. That does not eliminate the cross-border risk; on the contrary, exchanges between the two countries remain constant, and the WHO and Africa CDC have called for stronger coordination.

This regional dimension matters for the DRC, a member of the East African Community and SADC, as well as for Central Africa and the Great Lakes region as a whole. An outbreak that is not contained in eastern Congo could disrupt trade chains, health corridors and the movement of workers far beyond the affected areas. That is why the response cannot be viewed as a purely local crisis.

At continental level, the Ebola crisis is also a reminder. Africa is building up its own capacities in surveillance, clinical trials and data production, with Africa CDC at the forefront. The current episode shows that an international alert alone is not enough. Laboratories, supply chains, mobile teams and public trust strong enough to break transmission are also needed. This network, more than dramatic announcements, will determine whether the DRC manages to contain this outbreak.

Automatic translation. Original French version

News quiz

Edition DR CongoDR Congo: the news quiz for 14–15 November

5 questions